Patients with permanently liver-limited disease had significantly lower KRAS mutation rates compared to those with extrahepatic or mixed metastatic patterns. (ESMO Gastrointest Oncol)
Liver-only metastases show lower KRAS mutation prevalence
The CRC Digest